Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 413

1.

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M, Desikan R, Shaver MJ, Fassas A, McConnell S, Muwalla F, Barri Y, Anaissie E, Munshi N, Tricot G.

Br J Haematol. 2001 Sep;114(4):822-9.

PMID:
11564069
[PubMed - indexed for MEDLINE]
2.

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years.

Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M, Fassas A, Anaissie E, Munshi N, Tricot G.

Br J Haematol. 2001 Sep;114(3):600-7.

PMID:
11552985
[PubMed - indexed for MEDLINE]
3.

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.

Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404.

PMID:
15148493
[PubMed - indexed for MEDLINE]
4.

Autotransplants in multiple myeloma: what have we learned?

Vesole DH, Tricot G, Jagannath S, Desikan KR, Siegel D, Bracy D, Miller L, Cheson B, Crowley J, Barlogie B.

Blood. 1996 Aug 1;88(3):838-47.

PMID:
8704239
[PubMed - indexed for MEDLINE]
Free Article
5.

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

San Miguel JF, Lahuerta JJ, García-Sanz R, Alegre A, Bladé J, Martinez R, García-Laraña J, De La Rubia J, Sureda A, Vidal MJ, Escudero A, Pérez-Esquiza E, Conde E, García-Ruiz JC, Cabrera R, Caballero D, Moraleda JM, Leon A, Besalduch J, Hernandez MT, Rifon J, Hernandez F, Solano C, Palomera L, Parody R, Gonzalez JD, Mataix R, Maldonado J, Constela J, Carrera D, Bello JL, De Pablos JM, Pérez-Simón JA, Torres JP, Olanguren J, Prieto E, Acebede G, Peñarrubia MJ, Torres P, Díez-Martín JL, Rivas A, Sánchez JM, Díaz-Mediavilla J.

Hematol J. 2000;1(1):28-36.

PMID:
11920166
[PubMed - indexed for MEDLINE]
6.

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.

Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B.

Clin Cancer Res. 1996 Jun;2(6):947-52.

PMID:
9816255
[PubMed - indexed for MEDLINE]
Free Article
7.

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

Alegre A, Díaz-Mediavilla J, San-Miguel J, Martínez R, García Laraña J, Sureda A, Lahuerta JJ, Morales D, Bladé J, Caballero D, De la Rubia J, Escudero A, Díez-Martín JL, Hernández-Navarro F, Rifón J, Odriozola J, Brunet S, De la Serna J, Besalduch J, Vidal MJ, Solano C, Leon A, Sánchez JJ, Martínez-Chamorro C, Fernández-Rañada JM.

Bone Marrow Transplant. 1998 Jan;21(2):133-40.

PMID:
9489629
[PubMed - indexed for MEDLINE]
Free Article
8.

Long-term follow-up after high-dose therapy for high-risk multiple myeloma.

Barlogie B, Jagannath S, Naucke S, Mattox S, Bracy D, Crowley J, Tricot G, Alexanian R.

Bone Marrow Transplant. 1998 Jun;21(11):1101-7.

PMID:
9645572
[PubMed - indexed for MEDLINE]
Free Article
9.

Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment.

Clark AD, Douglas KW, Mitchell LD, McQuaker IG, Parker AN, Tansey PJ, Franklin IM, Cook G.

Br J Haematol. 2002 Jun;117(3):605-12. Erratum in: Br J Haematol 2002 Sep;118(4):1201.

PMID:
12028028
[PubMed - indexed for MEDLINE]
10.

Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.

Palumbo A, Triolo S, Baldini L, Callea V, Capaldi A, De Stefano V, Grasso M, Liberati M, Lotesoriere C, Marcenò R, Marmont F, Musto P, Petrucci MT, Spriano M, Pileri A, Boccadoro M.

Haematologica. 2000 May;85(5):508-13.

PMID:
10800168
[PubMed - indexed for MEDLINE]
Free Article
11.

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.

Tosi P, Zamagni E, Ronconi S, Benni M, Motta MR, Rizzi S, Tura S, Cavo M.

Leukemia. 2000 Jul;14(7):1310-3.

PMID:
10914557
[PubMed - indexed for MEDLINE]
12.

Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.

Novitzky N, Thomson J, Thomas V, du Toit C, Mohamed Z, McDonald A.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1402-10. doi: 10.1016/j.bbmt.2010.04.002. Epub 2010 Apr 10.

PMID:
20385248
[PubMed - indexed for MEDLINE]
13.

Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy.

Singhal S, Mehta J, Desikan K, Siegel D, Singh J, Munshi N, Spoon D, Anaissie E, Ayers D, Barlogie B.

Bone Marrow Transplant. 1999 Jul;24(1):13-7.

PMID:
10435728
[PubMed - indexed for MEDLINE]
Free Article
14.

Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.

Kröger N, Zeller W, Hassan HT, Krüger W, Renges H, Hummel K, Gutensohn K, Lölliger C, Zander AR.

Ann Hematol. 1998 Jun;76(6):257-62.

PMID:
9692813
[PubMed - indexed for MEDLINE]
15.

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B.

Blood. 1995 Jan 15;85(2):588-96. Review.

PMID:
7529066
[PubMed - indexed for MEDLINE]
Free Article
16.

Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.

Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.

Transfusion. 2007 Dec;47(12):2207-16. Epub 2007 Aug 21.

PMID:
17714420
[PubMed - indexed for MEDLINE]
17.

Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma.

Abraham R, Chen C, Tsang R, Simpson D, Murray C, Davidson M, Meharchand J, Sutton DM, Crump RM, Keating A, Stewart AK.

Bone Marrow Transplant. 1999 Dec;24(12):1291-7.

PMID:
10627637
[PubMed - indexed for MEDLINE]
Free Article
18.

Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.

Tribalto M, Amadori S, Cudillo L, Caravita T, Del Poeta G, Meloni G, Avvisati G, Petrucci MT, Pulsoni A, Leone G, Sica S, Martelli M, Tabilio A, Fioritoni G, Majolino I, Mandelli F.

Haematologica. 2000 Jan;85(1):52-8.

PMID:
10629592
[PubMed - indexed for MEDLINE]
Free Article
19.

High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J, Sharma A, Singh R, Kochupillai V.

Natl Med J India. 2003 Jan-Feb;16(1):16-21.

PMID:
12715951
[PubMed - indexed for MEDLINE]
20.

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R.

Ann Oncol. 1997 Mar;8(3):243-6.

PMID:
9137792
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk